SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Klevebring Daniel)
 

Search: WFRF:(Klevebring Daniel) > (2016) > Reprogramming Tumor...

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

Georgoudaki, Anna-Maria (author)
Karolinska Institutet
Prokopec, Kajsa E. (author)
Boura, Vanessa F. (author)
Karolinska Institutet
show more...
Hellqvist, Eva (author)
Sohn, Silke (author)
Karolinska Institutet
Ostling, Jeanette (author)
Dahan, Rony (author)
Harris, Robert A. (author)
Karolinska Institutet
Rantalainen, Mattias (author)
Karolinska Institutet
Klevebring, Daniel (author)
Sund, Malin (author)
Umeå universitet,Kirurgi
Brage, Suzanne Egyhazi (author)
Fuxe, Jonas (author)
Karolinska Institutet
Rolny, Charlotte (author)
Karolinska Institutet
Li, Fubin (author)
Ravetch, Jeffrey V. (author)
Karlsson, Mikael C. I. (author)
Karolinska Institutet
show less...
 (creator_code:org_t)
Elsevier BV, 2016
2016
English.
In: Cell Reports. - : Elsevier BV. - 2211-1247. ; 15:9, s. 2000-2011
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Tumors are composed of multiple cell types besides the tumor cells themselves, including innate immune cells such as macrophages. Tumor-associated macrophages (TAMs) are a heterogeneous population of myeloid cells present in the tumor microenvironment (TME). Here, they contribute to immunosuppression, enabling the establishment and persistence of solid tumors as well as metastatic dissemination. We have found that the pattern recognition scavenger receptor MARCO defines a subtype of suppressive TAMs and is linked to clinical outcome. An anti-MARCO monoclonal antibody was developed, which induces anti-tumor activity in breast and colon carcinoma, as well as in melanoma models through reprogramming-TAM-populations to a pro-inflammatory phenotype and increasing tumor immunogenicity. This anti-tumor activity is dependent on the inhibitory Fc-receptor, Fc gamma RIIB, and also enhances the efficacy of checkpoint therapy. These results demonstrate that immunotherapies using antibodies designed to modify myeloid cells of the TME represent a promising mode of cancer treatment.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin -- Cancer och onkologi (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine -- Cancer and Oncology (hsv//eng)

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view